SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Allogene Therapeutics Inc. (ALLO) on Thursday reported a loss of $66.3 million in its third quarter.
On a per-share basis, the South San Francisco, California-based company said it had a loss of 32 cents. Losses, adjusted for asset impairment costs, were 27 cents per share.
The results exceeded Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for a loss of 34 cents per share.
In the final minutes of trading on Thursday, the company’s shares hit $3.20. A year ago, they were trading at $3.28.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ALLO at https://www.zacks.com/ap/ALLO
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
